Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DP13 phase II trial in primary aldosteronism
NL-OMON54894Phase 2Active, not recruiting
- Sponsor
- Damian Pharma AG
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexfadrostat in primary aldosteronism (PA), sponsored by Damian Pharma AG. Started Aug 2020; status: active, not recruiting.
02
Drugs
dexfadrostat
03
Conditions
primary aldosteronism (PA)
Beyond the preview
Go deeper on NL-OMON54894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54894.